Menu

About Us
GeM Registration
Company Insights

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6126607)

Inj Nano Liposomal Docetaxel vial of 20 mg,Isavuconazole 100 mg Cap,POMALIDOMIDE 4 MG TAB,Darbepoie

Pune, Maharashtra
Goods
Qty:5,286
EMD: ₹19,656
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6126607)

Tender Timeline

Tender Issue
April 30, 2025 at 1:11 PM

Tender Title: POMALIDOMIDE 4 MG TAB
Tender Reference Number: GEM/2025/B/6126607
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence

The purpose of this tender is to solicit bids for the supply of specialized pharmaceutical products, including POMALIDOMIDE 4 MG TAB, Inj Nano Liposomal Docetaxel vial of 20 mg, Isavuconazole 100 mg Cap, and Darbepoietin 500 mcg inj. This procurement is designed to fulfill the medical supply requirements of military and defense operations, ensuring that all enlisted personnel have access to essential medications necessary for their health and operational readiness.

Scope of Work and Objectives

The scope of work encompasses the procurement and delivery of the listed pharmaceutical products in the specified quantities, totaling 5286 units. The main objective is to ensure uninterrupted supply, high quality of medicines, and adherence to regulatory medical standards. Suppliers must demonstrate capability in handling, transporting, and delivering pharmaceutical products safely and efficiently.

Eligibility Criteria

To qualify for this tender, bidders must meet certain eligibility requirements including:

  • Being a registered entity under applicable Indian laws.
  • Compliance with all necessary certifications for pharmaceutical procurement.
  • Proven track record in similar contracts, showcasing experience in medical supplies.

Technical Requirements

Bidders must comply with the following technical specifications:

  • All products must be latest pharmaceutical formulations and conform to the quality standards prescribed by the Drug Control Authority.
  • Necessary packaging and labelling standards must be strictly adhered to, reflecting batch numbers and expiry dates.
  • Proof of previous supply and quality assurance certifications may be required.

Financial Requirements

Bidders should demonstrate financial stability as part of financial requirements:

  • Submission of price quotes in alignment with the market standards.
  • Potential requirement for Earnest Money Deposit (EMD), confirming commitment to the tender.
  • Compliance with payment terms decided post-contract agreement.

Document Submission Details

All bids must be submitted through the designated online procurement platform. Required documentation includes:

  • Duly filled bid forms.
  • Certified copies of eligibility documents.
  • Price quotes and descriptions of the offered products.

Special Provisions

This tender includes special provisions for Micro, Small and Medium Enterprises (MSEs) to encourage participation and support local businesses. Startups are also encouraged through relaxed eligibility criteria and assistance in fulfilling documentation requirements.

Evaluation Process

The evaluation process will incorporate both technical and financial assessments to ensure comprehensive review and selection of bidders.

  • Technical capability, quality assurance, and prior experience will be evaluated first.
  • Financial bids will be inspected for legality and competitiveness, focusing on overall value for the government.

Delivery Locations

Successful suppliers will be required to deliver products to designated locations as specified in the tender documentation. It is crucial that all deliveries are conducted in compliance with relevant logistics protocols to maintain medication integrity and efficiency.

Contact Information

For our bidders’ convenience, further details and clarifications can be obtained through the official procurement channel. Please ensure that all communications are directed through the established avenues provided in the tender documentation.

Tender BOQ Items

7 Items
1.

Inj Nano Liposomal Docetaxel vial of 20 mg

Qty:60
Unit:amp vial
30
2.

Isavuconazole 100 mg Cap

Qty:168
Unit:no
30
3.

POMALIDOMIDE 4 MG TAB

Qty:1200
Unit:no
30
4.

Darbepoietin 500 mcg inj

Qty:21
Unit:vial
30
5.

CHLORHEXIDINE GLUCONATE 2 percent IN 70 percent ISOPROPYL ALCOHOL 500 ML BOTT

Qty:1878
Unit:bott
30
6.

10percentE IODINE SOLUTION USP EQUIVALENT TO 1 percent AVAILABLE IODINE 500 ML BOTT

Qty:1881
Unit:bott
30
7.

Omalizumab 150mg solution for injection in each 1 ml Pre Filled Syringe PFS

Qty:78
Unit:pfs
30

General Information

Item Category
Inj Nano Liposomal Docetaxel vial of 20 mg , Isavuconazole 100 mg Cap , POMALIDOMIDE 4 MG TAB , Darbepoietin 500 mcg inj , CHLORHEXIDINE GLUCONATE 2 percent IN 70 percent ISOPROPYL ALCOHOL 500 ML BOTT , 10percentE IODINE SOLUTION USP EQUIVALENT TO 1 percent AVAILABLE IODINE 500 ML BOTT , Omalizumab 150mg solution for injection in each 1 ml Pre Filled Syringe PFS
Ministry Name
Ministry of Defence
Department Name
Department of Military Affairs
Organisation Name
Indian Army
State
Maharashtra
City
Pune

Financial Information

EMD Amount
₹19,656.00
OEM Average Turnover
₹12.00 Lakh (s)
Minimum Turnover
₹12.00 Lakh (s)
Bid Offer Validity
180 (Days)
Past Performance
30 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
3 Days

Tender Documents

4 Documents
GeM-Bidding-7724770.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Inj Amino Acids,Inj Ciprofloxacin,Inj Compound Sodium Lactate Solution,Inj Dextrose 5 percent,Inj D

GEM
Goods
Qty:7.9L
6 Files
N/a
CENTRAL DELHI, DELHI
Boq › Boql
Inj Amino Acids , Inj Ciprofloxacin , Inj Compound Sodium Lactate Solution , Inj Dextrose 5 percent , Inj Dextrose 10percent 500ml , Inj Dextrose 25percent 100ml , Inj Dextrose 50percent 100ml , Inj Dextrose 5percent , Distilled Water 5 Ltr Can , Inj Fat Emulsion 10percent 500 ml , Inj Fluconazole 200 mg , Inj Haemaccel 500 ml , Inj Albumin 20percent 50 ml , Inj Albumin 20percent 100 ml , Inj Immunoglobulin 5 gm per 100 ml , Inj Hydroxyl Ethyl Starch 6percent , Inj Linezolid 600 mg , Inj Levofloxacin 500 mg , Inj Mannitol 20percent , Inj Metronidazole 500 mg , Paediatric maintenance infusion , Inj Ofloxacin , Inj Paracetamol Infusion 1000 mg , Inj Sodium Chloride , Inj Sodium Cloride 3percent 250 ml , Inj 3 in 1 TPN 1000 ml , Inj Isotonic Electrolyte Solution Lactate Free 500 ml , Sterile Water for Inj 500 ml , Potassium free Hemodialysis fluid 5L , Haemodialysis Fluid Part A 5l for HD Machine , Calcium free Hemodialysis FLUID 5L , Bicarb Powder part B for HD machine , Haemodialysis Fluid
April 22, 2025
May 22, 2025 at 12:00 PM
View Details

D IFA RE 24 Cycloserine 250 mg Cap,D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml

₹6.00
GEM
Goods
Qty:19.3K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 24 Cycloserine 250 mg Cap , D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml , D IFA RE 24 Fluticasone propionate inhaler for paed use 50mcg dose 120 metered doses , D IFA RE 24 Fluticasone Propionate Inhaler for Adults 125 mcg dose , D IFA RE 24 Salmeterol 50 mcg plus Fluticasone 250 mcg multi dose dry powder inhaler of 60 doses , D IFA RE 24 Salmeterol Rotacap 50mcg , D IFA RE 24 Theophylline SR 400 mg Tab , D IFA RE 24 Fexofenadine Hydrochloride Tab 120 mg , D IFA RE 24 Glucosamine 250 mg plus Chondroitin Sulphate 200 mg Cap , D IFA RE 24 Immunoglobulin Intravenous 2 DOT 5 gm Inj , D IFA RE 24 Ibuprofen Gel tube of 20 gm , D IFA RE 24 Leflunomide 20 mg Tab , D IFA RE 24 Naproxen gel tube of 20 gm , D IFA RE 24 Nimesulide gel tube of 20 gm , D IFA RE 24 Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml , D IFA RE 24 Amikacin Sulphate 250 mg 2 ml Inj , D IFA RE 24 Norfloxacin 400 mg Tab , D IFA RE 24 Ofloxacin 200 mg Tab , D IFA RE 24 Sulphamethoxazole 200 mg and Trimethoprim 40 mg per 5 ml bottle of 50 60 ml suspension , D IFA RE 24 Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab , D IFA RE 24 Acyclovir 250 mg Inj , D IFA RE 24 Acyclovir Syp 400 mg 5 ml , D IFA RE 24 Linezolid 2 mg ml 300 ml Inj , D IFA RE 24 Oseltamivir 75 mg Cap , D IFA RE 24 Brimonidine 0 DOT 2 and Brinzolamide 1 Eye Drop Bott of 5ml , D IFA RE 24 Nepafenac mocronised suspension 0 DOT 1 BAK free in 5 ml bottle , D IFA RE 24 Nitroglycerine Glyceryltrinitrate 5mg Inj , D IFA RE 24 Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 ml bottle , D IFA RE 24 Methotrexate 15mg Tab , D IFA RE 24 Paroxetine 25mg Tab , D IFA RE 24 Baclofen XL 30 mg Tab , D IFA RE 24 Clozapine 50 mg Tab , D IFA RE 24 Thiamine 100mg ml Inj 2ml Amp , D IFA RE 24 MDI spacer with mask and fish mouth valve for pediatrics set , D IFA RE 24 Fluticasone Propionate and Formoterol 120 MDI , D IFA RE 24 Cabergoline 0 DOT 25mg Tab , D IFA RE 24 Misoprostol 600mcg Tab , D IFA RE 24 Diclofenac 75mg ml Inj 1ml Amp for IV bolus , D IFA RE 24 Silicone Ring Vaginal Pessary , D IFA RE 24 Cell Culture Rabies Vaccine vial of 1 ml , D IFA RE 24 Test Mantoux Sufficent for 10 tests , D IFA RE 24 Airway long transparent Oropharyngeal set consisting of size Length 000 3 DOT 5 00 5 DOT 0 0 5 DOT 0 1 7 DOT 0 2 9 DOT 0 3 10 DOT 0 4 1 DOT 0 , D IFA RE 24 Adhesive Incise drape 50 x 45 cm , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 0 infant , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 1 paediatric , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 3 adult with valve , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 4
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

D IFA22 Caffeine Citrate 20 mgml Inj 1ml vial,D IFA22 Salmeterol 25 mcg plus Fluticasone 125 mg MDI

GEM
Goods
Qty:26.4K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA22 Caffeine Citrate 20 mgml Inj 1ml vial , D IFA22 Salmeterol 25 mcg plus Fluticasone 125 mg MDI 120 doses , D IFA22 Caffeine Citrate 20mgml Oral Solution 1ml Syp , D IFA22 Fluconazole 10 mgml 30 ml Syp , D IFA22 Linezolid dry powder 100mg30ml , D IFA22 Frusemide 10 mgml 30 ml Syp , D IFA22 Domperidone Syp 1 mgml bott of 30 ml , D IFA22 Dicyclomine drops of 15 ml , D IFA22 Norflox Syp 100mg5ml bott of 30 ml , D IFA22 Phenobarbitone Syp 20 mg5 ml bott of 60 ml , D IFA22 Prednisolone Syp 5mg5ml in bott of 30 ml , D IFA22 Roxithromycin 50mg5ml Syp in bott of 30 ml , D IFA22 Natural Surfactant 25 to 80mgml Inj , D IFA22 Triclofos Syp 500 mg5ml in 30ml bottle , D IFA22 Human Milk fortifier 2 gm sachet , D IFA22 Calcium Phosphate 80 mg5 ml Syp 200ml bott , D IFA22 Bupropion HCl 150 mg SR Tab , D IFA22 Buspirone HCl 10 mg Tab , D IFA22 Clonazepam 0dot5 mg Tab , D IFA22 Clomipramine HCl 25 mg Tab , D IFA22 Doxepin HCl 75 mg Cap , D IFA22 Fluoxetine HCl 20 mg Cap , D IFA22 Haloperidol decanoate 50 mgml Inj in 1ml amp , D IFA22 Imipramine 25 mg Tab , D IFA22 Lithium Carbonate 300 mg CapTab , D IFA22 Memantine 5 mg Tab , D IFA22 Aripiprazole 10 mg Tab , D IFA22 Zolpidem 10 mg Tab , D IFA22 Quetiapine 50 mg Tab , D IFA22 Paroxetine XR 12dot5 Tab , D IFA22 Amisulpride 200mg Tab , D IFA22 Theophylline anhydrous syrup 60 mg in 5 ml as 100ml bottledot , D IFA22 Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI , D IFA22 Salmeterol 50 mcg plus Fluticasone 500 mcg Accuhaler , D IFA22 Cough Syrup Each 5 ml contains Chlorpheniramine Maleate IP 3 mg Ammonium Chloride IP 110 mg Sodium Citrate IP 46 mg Menthol IP 0dot9 mg Bott of 110 ml , D IFA22 Cough expectorant syp 5 ml containingDiphenhydramine HCl 14dot08mg AmmoniumChloride 0dot138 gm Sodium Citrate 57dot03mg Menthol 1dot14 mg in flavoured syp basebott of 100 110 ml , D IFA22 Codeine Phosphate 10 mg plus Chlorpheniramine Maleate 4 mg per 5 ml Syp bottle of 100 ml , D IFA22 Disodium Hydrogen Citrate Syp Bott of 100ml , D IFA22 Antimicrobial Hand Gel Containing Ethyl Alcohol 60prcntge plus Cyclomethicone C1215 Alkyl Lactate plus Cetyl Lactate plus Phenoxyethanol plus Stearyl Alcohol with moisturizer , D IFA22 Anti phlebitis cream Tube of 15 g20 g , D IFA22 Haemostatic sponge gelatin 80 mm long 50mm broad 10 mm thick , D IFA22 Desmopressin Nasal spray 0dot1 mgml in vial of 2dot5 ml , D IFA22 Vit B1 50 mg Inj , D IFA22 Vitamin A solution IP 50 ml , D IFA22 Calcium 9 mg plus Calcium gluconate 50 mg Inj for IV use 10 ml Injection , D IFA22 Iron Syp Paediatric each 5 ml containing elemental Iron 2550 mg and Folic Acid 500 mcg bottle of 200 ml , D IFA22 Multi Vit Inj IV 210 ml with minimum constituents having Thiamine B130mgml Pyridoxine B6 30mgml and B12 Cyanocobalamin300 mcgml , D IFA22 Niacin 500mg Tab , D IFA22 Drop VitaminD3 Cholecalciferol 200 IUml , D IFA22 Dapagliflozin 5 mg plus Metformin 1000 mg IR Tab
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Di

₹158.00
GEM
Goods
Qty:11.6K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen , D IFA RE 21 Gliclazide MR 30 mg Tab , D IFA RE 21 Glipizide 5mg Tab , D IFA RE 21 Sitagliptin 50 mg Metformin 1000 mg Tab , D IFA RE 21 Insulin Lispro Biphasic injection I DOT P 25 Insulin Lispro and 75 Insulin Lispro protamine suspension , D IFA RE 21 Sirolimus 1mg Tab , D IFA RE 21 Pioglitazone Hydrochloride 15mg Tab , D IFA RE 21 Alendronate Sodium 70mg Tab , D IFA RE 21 Neostigmine 0 DOT 5mg 1ml Inj , D IFA RE 21 Cisatracurium 2 mg ml Inj 10ml vial , D IFA RE 21 Tacrolimus 1mg Prolonged Release Cap , D IFA RE 21 Mycophenolate Mofetil 750mg Tab , D IFA RE 21 Intravenous Immunoglobulin IvIg 10gm Bott of 50ml , D IFA RE 21 Calcium Phosphate 0 DOT 24 mg 5 ml Syp , D IFA RE 21 Calcium Acetate 500 mg Tab , D IFA RE 21 Carnitine 200 mg Tab , D IFA RE 21 Acyclovir Ophth Ointment 3 w w in 5 gm tube , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Tube of 5 gm , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Dexamethasone DOT 1 bott of 5ml , D IFA RE 21 Cyclosporine eye drop 0 DOT 05 bott of 3 ml , D IFA RE 21 Fluorescein Sodium 20 3 ml Inj , D IFA RE 21 Flurbiprofen Sodium ophthalmic soln 0 DOT 03 vial of 5 ml , D IFA RE 21 Homatropine Hydrochloride Soln 2 , D IFA RE 21 Ketorolac Tromethamine 0 DOT 4 Eye drops , D IFA RE 21 Natamycin 3 eye drops in 3 ml bott , D IFA RE 21 Carboxy Methyl Cellulose CMC 1 Gel , D IFA RE 21 Ofloxacin 0 DOT 3 bott of 5 ml , D IFA RE 21 Pilocarpine Nitrate eye solution 2 bott of 5 ml , D IFA RE 21 Pilocarpine Intracameral Inj 0 DOT 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each , D IFA RE 21 Prednisolone acetate 1 w v bott of 5 ml , D IFA RE 21 Sodium Chloride 6 w w ointment Tube of 3 gm , D IFA RE 21 Azelaic acid 20 cream tube of 15 gm , D IFA RE 21 Cream Luliconazole tube of 15 gm , D IFA RE 21 Tobramycin 0 DOT 3 bott of 5 ml , D IFA RE 21 Tropicamide 1 with 5 Phenylephrine eye drops bott of 5 ml , D IFA RE 21 Tropicamide Eye solution 1 bott of 5 ml , D IFA RE 21 Trypan Blue 0 DOT 6 Inj in vial of 1ml , D IFA RE 21 Amphotericin B 0 DOT 5 eye drops bott of 5 ml , D IFA RE 21 Atropine Sulphate 1 w v Eye Drop Bott of 3 ml , D IFA RE 21 Atropine Sulphate Oint 1 Tube of 3gm , D IFA RE 21 Olopatadine Hydrochloride 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Olopatadine 0 DOT 2 Ophthalmic Soln bott of 5 ml , D IFA RE 21 Proparacaine Eye Drops 0 DOT 5 Bott of 5 ml , D IFA RE 21 Moxifloxacin HCl 0 DOT 5 and Dexamethasone 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Diphenhydramine 10 15 mg per 5 ml and Ammonium Chloride 100 150 mg Sodium Citrate 50 85 mg per 5ml Syp Bott of 100ml , D IFA RE 21 Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units , D IFA RE 21 Betahistine Dihydrochloride 16mg Tab , D IFA RE 21 Clotrimazole 1 w v IP Lignocaine 2 w v IP ear drop bott of 10ml , D IFA RE 21 Chloramphenicol 5 w v Clotrimazole 1 w v Betamethasone 0 DOT 25 w v Lignocaine HCl 2 w v in bott of 5 ml , D IFA RE 21 Xylometazoline HCl 0 DOT 05 w v nasal solution for paed use bott of 10ml
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity with the relevant government authorities, adequate compliance with pharmaceutical regulations, and a successful track record of handling similar supply contracts. Bidders must also possess the necessary certifications that validate their operational capabilities in supplying medical products.

Bidders need to provide various required certificates to participate effectively in the tender, including registration as a pharmaceutical supplier, quality assurance certifications (such as ISO), and any other relevant licenses issued by health authorities. All certificates should be current and valid.

To complete the registration process, interested bidders must access the official procurement portal, create an account, and submit the necessary documentation online. Ensure all required fields are filled out accurately, and all supporting documents are uploaded in the accepted formats to avoid disqualification.

The submission must be made in standard document formats, typically including PDF and Word formats. Bid pricing should be presented in an Excel sheet as specified in the tender documentation, ensuring clarity and easy assessment.

MSEs are provided with specific benefits as part of the tendering process. These may include reduced eligibility criteria and potential assistance during the bidding step, aimed at promoting local businesses. Compliance with the government’s Make in India initiative is encouraged, promoting local sourcing and procurement rules.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders